147 related articles for article (PubMed ID: 36229904)
1. Statin Intake and Gastric Cancer Risk: An Updated Subgroup Meta-analysis Considering Immortal Time Bias.
Bae JM
J Prev Med Public Health; 2022 Sep; 55(5):424-427. PubMed ID: 36229904
[TBL] [Abstract][Full Text] [Related]
2. Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study.
Cho MH; Yoo TG; Jeong SM; Shin DW
Cancer Prev Res (Phila); 2021 Jan; 14(1):95-104. PubMed ID: 32938643
[TBL] [Abstract][Full Text] [Related]
3. Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis.
Seo SI; Park CH; Kim TJ; Bang CS; Kim JY; Lee KJ; Kim J; Kim HH; You SC; Shin WG
Cancer Med; 2022 Feb; 11(4):1217-1231. PubMed ID: 34970858
[TBL] [Abstract][Full Text] [Related]
4. Statin Use and Liver Cancer Risk: A Meta-Epidemiological Study of Retrospective Cohort Studies by the Types of Constructed Cohort.
Bae JM
Asian Pac J Cancer Prev; 2024 Mar; 25(3):777-783. PubMed ID: 38546060
[TBL] [Abstract][Full Text] [Related]
5. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
[TBL] [Abstract][Full Text] [Related]
6. Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer.
Emilsson L; García-Albéniz X; Logan RW; Caniglia EC; Kalager M; Hernán MA
JAMA Oncol; 2018 Jan; 4(1):63-70. PubMed ID: 28822996
[TBL] [Abstract][Full Text] [Related]
7. Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated
Cheung KS; Chan EW; Wong AYS; Chen L; Seto WK; Wong ICK; Leung WK
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):493-499. PubMed ID: 31792089
[TBL] [Abstract][Full Text] [Related]
8. Inverse Association between Statin Use and Stomach Cancer Incidence in Individuals with Hypercholesterolemia, from the 2002-2015 NHIS-HEALS Data.
You HS; You N; Lee JW; Lim HJ; Kim J; Kang HT
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32046107
[No Abstract] [Full Text] [Related]
9. Immortal time bias exaggerates the effect of metformin on the risk of gastric cancer: A meta-analysis.
Wang YB; Tan LM; Luo L; Yan S; Huang Q; Wang Y; Deng T; Shi Y; Deng Y; Jin YH
Pharmacol Res; 2021 Mar; 165():105425. PubMed ID: 33453371
[TBL] [Abstract][Full Text] [Related]
10. Effect of Statin Use on Liver Cancer Mortality Considering Hypercholesterolemia and Obesity in Patients with Non-Cirrhotic Chronic Hepatitis B.
Kim GA; Shim JJ; Lee JS; Kim BH; Kim JW; Oh CH; Oh CM; Oh IH; Park SY
Yonsei Med J; 2019 Dec; 60(12):1203-1208. PubMed ID: 31769252
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects of statin use on gastric cancer prevention.
Fujita T
Am J Gastroenterol; 2012 May; 107(5):792. PubMed ID: 22552248
[No Abstract] [Full Text] [Related]
12. Statins are associated with reduced risk of gastric cancer: a meta-analysis.
Wu XD; Zeng K; Xue FQ; Chen JH; Chen YQ
Eur J Clin Pharmacol; 2013 Oct; 69(10):1855-60. PubMed ID: 23748751
[TBL] [Abstract][Full Text] [Related]
13. Effect of statins on gastric cancer incidence: a meta-analysis of case control studies.
Ma Z; Wang W; Jin G; Chu P; Li H
J Cancer Res Ther; 2014; 10(4):859-65. PubMed ID: 25579519
[TBL] [Abstract][Full Text] [Related]
14. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
[TBL] [Abstract][Full Text] [Related]
15. Association between statins' exposure with incidence and prognosis of gastric cancer: an updated meta-analysis.
Lou D; Fu R; Gu L; Su H; Guan L
Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1127-1138. PubMed ID: 35947078
[TBL] [Abstract][Full Text] [Related]
16. Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study.
Mamtani R; Lewis JD; Scott FI; Ahmad T; Goldberg DS; Datta J; Yang YX; Boursi B
PLoS Med; 2016 Apr; 13(4):e1002007. PubMed ID: 27116322
[TBL] [Abstract][Full Text] [Related]
17. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
18. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.
Jian-Yu E ; Graber JM; Lu SE; Lin Y; Lu-Yao G; Tan XL
Curr Med Chem; 2018; 25(22):2595-2607. PubMed ID: 28403788
[TBL] [Abstract][Full Text] [Related]
19. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
[TBL] [Abstract][Full Text] [Related]
20. Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis.
Weberpals J; Jansen L; Carr PR; Hoffmeister M; Brenner H
Cancer Treat Rev; 2016 Jun; 47():1-11. PubMed ID: 27179912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
